Literature DB >> 54713

Letter: Immunoblactic lymphadenopathy associated with phenytoin (diphenylhydantoin).

M J Lapes, R J Vivacqua, K Antoniades.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 54713     DOI: 10.1016/s0140-6736(76)91307-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Studies on the adjuvant action of beryllium. IV. The preparation of beryllium containing macromolecules that induce immunoblast responses in vivo.

Authors:  J G Hall
Journal:  Immunology       Date:  1988-06       Impact factor: 7.397

2.  Angioimmunoblastic lymphadenopathy, immunoblastic sarcoma of B cells. Animal model: autoimmune-prone inbred Armenian hamster.

Authors:  G Yerganian; H J Gagnon; A Battaglino
Journal:  Am J Pathol       Date:  1978-04       Impact factor: 4.307

3.  Angioimmunoblastic lymphadenopathy, sulphasalazine exposure and villous atrophy.

Authors:  M A Smith; P R Steele; G R Youngs
Journal:  Postgrad Med J       Date:  1985-04       Impact factor: 2.401

Review 4.  Immunological adverse effects of anticonvulsants. What is their clinical relevance?

Authors:  F De Ponti; S Lecchini; M Cosentino; C M Castelletti; A Malesci; G M Frigo
Journal:  Drug Saf       Date:  1993-03       Impact factor: 5.606

5.  Clonality of angioimmunoblastic lymphadenopathy and implications for its evolution to malignant lymphoma.

Authors:  E H Lipford; H R Smith; S Pittaluga; E S Jaffe; A D Steinberg; J Cossman
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

6.  Immunological studies in angioimmunoblastic lymphadenopathy.

Authors:  A Skibin; T Yeremiyahu; A Keynan; M R Quastel
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

7.  Malignant progression of angioimmunoblastic lymphadenopathy.

Authors:  M Bamberg; K Donhuijsen; P G Höher; H Holfeld; D K Hossfeld
Journal:  J Cancer Res Clin Oncol       Date:  1979-04-12       Impact factor: 4.553

8.  Angioimmunoblastic lymphadenopathy associated with polyarthritis.

Authors:  R S Rothwell; M J Mant; P Davis
Journal:  Ann Rheum Dis       Date:  1980-08       Impact factor: 19.103

9.  Immunoblastic lymphadenopathy: evolution into immunoblastic sarcoma.

Authors:  S Banik; R L Ward; P S Hasleton
Journal:  J Clin Pathol       Date:  1979-11       Impact factor: 3.411

10.  [Immunoblastic lymphadenopathy--malignant neoplasia or hyperimmune reaction? (author's transl)].

Authors:  A Schoengen; H Feyen; O Haferkamp; H Heimpel; B Kubanek
Journal:  Klin Wochenschr       Date:  1977-03-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.